Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Clement Twumasi Sally Moore Ross SadlerSally JeansSherin Varghese Alison Turner Gaurav AgarwalJemma LarhamNathanael GrayOluremi CartyJoe BarrettStella Bowcock Udo OppermannVicky GambleCurly T C M MorrisChara KyriakouMark T Drayson Supratik BasuSarah McDonaldShelagh McKinleySarah Gooding Muhammad Kassim Javaid Karthik Ramasamy

Published in: European journal of haematology (2023)

Negative T-spot results predict low Anti-S antibody levels (<50 IU/mL) following a second COVID-19 vaccination and a number of biomarkers predict T cell responses in myeloma patients.

Keyphrases

newly diagnosed
end stage renal disease
coronavirus disease
sars cov
ejection fraction
prognostic factors
immune response
peritoneal dialysis